ID: ALA4590811

Max Phase: Preclinical

Molecular Formula: C151H234N52O47S6

Molecular Weight: 3722.25

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CC[C@H](C)[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN)CSSC[C@H]2NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H]3CCCN3C(=O)[C@@H]3CSSC[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc4c[nH]c5ccccc45)NC1=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N3)NC(=O)[C@H]([C@@H](C)CC)NC2=O

Standard InChI:  InChI=1S/C151H234N52O47S6/c1-6-73(3)118-144(246)192-92(52-78-57-170-82-28-12-11-26-80(78)82)134(236)186-84(29-14-17-43-153)126(228)184-85(30-15-18-44-154)129(231)197-101-68-252-254-70-103-140(242)183-83(31-19-45-166-148(158)159)122(224)172-60-112(213)180-93(53-108(157)209)123(225)173-61-111(212)179-90(51-77-36-38-79(207)39-37-77)132(234)196-100(125(227)175-63-113(214)181-97(64-204)124(226)174-62-114(215)182-98(65-205)137(239)193-96(147(249)250)56-117(220)221)67-251-256-72-105(200-136(238)95(55-116(218)219)191-138(240)99(66-206)194-135(237)94(54-115(216)217)190-128(230)87(33-21-47-168-150(162)163)185-127(229)86(188-139(101)241)32-20-46-167-149(160)161)146(248)203-49-23-35-106(203)143(245)176-58-109(210)177-75(5)120(222)195-104(142(244)202-119(74(4)7-2)145(247)199-103)71-255-253-69-102(198-130(232)89(40-41-107(156)208)178-110(211)59-171-121(223)81(155)27-13-16-42-152)141(243)189-91(50-76-24-9-8-10-25-76)133(235)187-88(131(233)201-118)34-22-48-169-151(164)165/h8-12,24-26,28,36-39,57,73-75,81,83-106,118-119,170,204-207H,6-7,13-23,27,29-35,40-56,58-72,152-155H2,1-5H3,(H2,156,208)(H2,157,209)(H,171,223)(H,172,224)(H,173,225)(H,174,226)(H,175,227)(H,176,245)(H,177,210)(H,178,211)(H,179,212)(H,180,213)(H,181,214)(H,182,215)(H,183,242)(H,184,228)(H,185,229)(H,186,236)(H,187,235)(H,188,241)(H,189,243)(H,190,230)(H,191,240)(H,192,246)(H,193,239)(H,194,237)(H,195,222)(H,196,234)(H,197,231)(H,198,232)(H,199,247)(H,200,238)(H,201,233)(H,202,244)(H,216,217)(H,218,219)(H,220,221)(H,249,250)(H4,158,159,166)(H4,160,161,167)(H4,162,163,168)(H4,164,165,169)/t73-,74-,75-,81-,83-,84-,85-,86-,87-,88-,89-,90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,100+,101-,102+,103-,104+,105-,106-,118-,119-/m0/s1

Standard InChI Key:  JEBHEQAGJNWHLB-OOUDVJKPSA-N

Associated Targets(Human)

Coagulation factor IX 922 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Coagulation factor X 9693 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Coagulation factor XII 1450 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Coagulation factor XI 1733 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Plasminogen 2339 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Trypsin 2137 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Thrombin 11687 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Plasma kallikrein 2047 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Tissue-type plasminogen activator 1057 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Urokinase-type plasminogen activator 2016 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 3722.25Molecular Weight (Monoisotopic): 3719.5843AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Swedberg JE, Mahatmanto T, Abdul Ghani H, de Veer SJ, Schroeder CI, Harris JM, Craik DJ..  (2016)  Substrate-Guided Design of Selective FXIIa Inhibitors Based on the Plant-Derived Momordica cochinchinensis Trypsin Inhibitor-II (MCoTI-II) Scaffold.,  59  (15): [PMID:27434175] [10.1021/acs.jmedchem.6b00557]

Source